Last update June 15, 2022

Азенапина Малеат

Likely Compatibility

Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.

Atypical or second generation antipsychotic used in the treatment of schizophrenia and bipolar disorder. Sublingual administration twice daily.

Since the last update we have not found published data on its excretion in breastmilk.

Its pharmacokinetic data (very high percentage of protein binding and very wide volume of distribution) make it highly unlikely that significant quantities will pass into breast milk.

Its practically zero oral bioavailability makes it difficult for it to pass to the infant plasma from ingested breast milk, except in premature infants and in the immediate neonatal period in which there may be greater intestinal permeability.

Clozapine has little or no significant effect on prolactin levels. (Peuskens 2014, Citrome 2014)

Until more published data is known about this drug in relation to breastfeeding, known safer alternatives are preferable (Klinger 2013), especially during the neonatal period and in the event of prematurity.


See below the information of this related product:

Alternatives

  • Olanzapine (Safe product and/or breastfeeding is the best option.)
  • Quetiapine Fumarate (Safe product and/or breastfeeding is the best option.)
  • Risperidone (Safe product and/or breastfeeding is the best option.)

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Азенапина Малеат is Asenapine Maleate in Cyrillic.

Is written in other languages:

Groups

Азенапина Малеат belongs to these groups or families:

Tradenames

Main tradenames from several countries containing Азенапина Малеат in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. subling: 35; oral: <2% %
Molecular weight 402 daltons
Protein Binding 95 %
VD 20 - 25 l/Kg
Tmax 0.5 - 1.5 hours
24 hours

References

  1. FDA. Asenapine. Org Summary. 2017 Full text (in our servers)
  2. EMA Asenapina Ficha técnica 2015 Full text (in our servers)
  3. Peuskens J, Pani L, Detraux J, De Hert M. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review. CNS Drugs. 2014 May;28(5):421-53. Abstract Full text (link to original source)
  4. Citrome L. Asenapine review, part II: clinical efficacy, safety and tolerability. Expert Opin Drug Saf. 2014 Jun;13(6):803-30. Abstract
  5. Klinger G, Stahl B, Fusar-Poli P, Merlob P. Antipsychotic drugs and breastfeeding. Pediatr Endocrinol Rev. 2013 Mar-Apr;10(3):308-17. Review. Abstract
  6. Bartlett JA, van der Voort Maarschalk K. Understanding the oral mucosal absorption and resulting clinical pharmacokinetics of asenapine. AAPS PharmSciTech. 2012 Abstract Full text (in our servers)

Total visits

660

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM